Top

Digestive Diseases and Sciences

Published in:

01-05-2012 | Original Article

Myosin Light Chain Kinase Is Involved in the Mechanism of Gastrointestinal Dysfunction in Diabetic Rats

Authors: Wenchao Hu, Ping Feng

Published in: Digestive Diseases and Sciences | Issue 5/2012

Abstract

Background

It is well established that smooth muscle contractility is regulated by an elevation of cytosolic Ca²⁺ via myosin light chain phosphorylation, which is activated by myosin light chain kinase (MLCK). Recently, MLCK has been demonstrated to play an important role in smooth muscle contraction and normal gastrointestinal motility.

Aims

The aim of our study is to investigate whether MLCK is involved in the mechanism of gastrointestinal dysfunction and the ameliorating effects of insulin on gastrointestinal dysfunction in diabetic rats.

Methods

A diabetic rat model was established by an intravenous injection with streptozotocin. Rats were randomized into three groups: control group, diabetic group, and insulin-treated group. The gastrointestinal functions were assessed in terms of gastric emptying and intestinal transit. The expression of MLCK in the pylorus and ileum of the three groups was determined by real-time polymerase chain reaction (PCR) and Western blot methods.

Results

The diabetic group exhibited a significant delay in gastric emptying and intestinal transit than the control group. Insulin treatment significantly ameliorated the gastric emptying and intestinal transit in diabetic rats. The expression levels of MLCK in the pylorus and ileum of the diabetic group were both significantly decreased compared with the control group, and the changes of MLCK expression in these tissues of diabetic rats were partially reversed after treatment with insulin.

Conclusions

Decreased expression of MLCK in gastrointestinal tissues could be a possible cause for gastrointestinal dysfunction. Insulin may partly ameliorate gastrointestinal dysfunction by restoring the expression of MLCK.

Horowitz M, O’Donovan D, Jones KL, Feinle C, Rayner CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med. 2002;19:177–194.PubMedCrossRef

El-Salhy M. Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). Int J Mol Med. 2009;24:727–732.PubMedCrossRef

Samsom M, Bharucha A, Gerich JE, et al. Diabetes mellitus and gastric emptying: questions and issues in clinical practice. Diabetes Metab Res Rev. 2009;25:502–514.PubMedCrossRef

Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem. 2003;278:48794–48804.PubMedCrossRef

Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177–185.PubMedCrossRef

He WQ, Peng YJ, Zhang WC, et al. Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice. Gastroenterology. 2008;135:610–620.PubMedCrossRef

Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest. 2000;106:373–384.PubMedCrossRef

Ward SM, Sanders KM. Interstitial cells of Cajal: primary targets of enteric motor innervation. Anat Rec. 2001;262:125–135.PubMedCrossRef

Horváth VJ, Vittal H, Ordög T. Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach. Diabetes. 2005;54:1528–1533.PubMedCrossRef

10.

Nakamura A, Xie C, Zhang Y, et al. Role of non-kinase activity of myosin light-chain kinase in regulating smooth muscle contraction, a review dedicated to Dr. Setsuro Ebashi. Biochem Biophys Res Commun. 2008;369:135–143.PubMedCrossRef

11.

Gao Y, Ye LH, Kishi H, et al. Myosin light chain kinase as a multifunctional regulatory protein of smooth muscle contraction. IUBMB Life. 2001;51:337–344.PubMedCrossRef

12.

Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG. Smooth muscle signalling pathways in health and disease. J Cell Mol Med. 2008;12:2165–2180.PubMedCrossRef

13.

Liu X, Takeda N, Dhalla NS. Myosin light-chain phosphorylation in diabetic cardiomyopathy in rats. Metabolism. 1997;46:71–75.PubMedCrossRef

14.

Mita M, Kuramoto T, Ito K, et al. Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-Kakizaki rats. Clin Exp Pharmacol Physiol. 2010;37:350–357.PubMedCrossRef

15.

Komers R, Oyama TT, Beard DR, Anderson S. Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats. Br J Pharmacol. 2011;162:163–174.PubMedCrossRef

16.

Clements RT, Sodha NR, Feng J, et al. Impaired coronary microvascular dilation correlates with enhanced vascular smooth muscle MLC phosphorylation in diabetes. Microcirculation. 2009;16:193–206.PubMedCrossRef

17.

Su X, Changolkar A, Chacko S, Moreland RS. Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylation. Am J Physiol Renal Physiol. 2004;287:F690–F699.PubMedCrossRef

18.

Miyamoto Y, Yoneda M, Morikawa A, Itoh H, Makino I. Gastric neuropeptides and gastric motor abnormality in streptozotocin-induced diabetic rats: observation for four weeks after streptozotocin. Dig Dis Sci. 2001;46:1596–1603.PubMedCrossRef

19.

Oztürk Y, Yildizoğlu-Ari N, Ozüari A, Altan VM. The effects of glyburide and insulin on the decreased beta-adrenergic responsiveness of the gastrointestinal tract in rats with non-insulin-dependent diabetes. Gen Pharmacol. 1994;25:1511–1517.PubMedCrossRef

20.

Pascaud X, Ferre JP, Genton M, Roger A, Ruckebusch M, Bueno L. Intestinal motility responses to insulin and glucagon in streptozotocin diabetic rats. Can J Physiol Pharmacol. 1982;60:960–967.PubMedCrossRef

21.

Reddy PM, Dkhar SA, Subramanian R. Effect of insulin on small intestinal transit in normal mice is independent of blood glucose level. BMC Pharmacol. 2006;6:4.PubMedCrossRef

22.

Huang WJ, Hung CR, Chen MC, et al. Involvement of cyclooxygenase 2 and prostagladin E(2) in the effects of insulin on gastric emptying in male rats. J Physiol Pharmacol. 2009;60:109–118.PubMed

23.

Izbéki F, Wittman T, Rosztóczy A, et al. Immediate insulin treatment prevents gut motility alterations and loss of nitrergic neurons in the ileum and colon of rats with streptozotocin-induced diabetes. Diabetes Res Clin Pract. 2008;80:192–198.PubMedCrossRef

Title: Myosin Light Chain Kinase Is Involved in the Mechanism of Gastrointestinal Dysfunction in Diabetic Rats
Authors: Wenchao Hu
Ping Feng
Publication date: 01-05-2012
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 5/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-012-2041-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Aims

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2012

A Nanofiber Membrane Maintains the Quiescent Phenotype of Hepatic Stellate Cells

Spiral Assisted ERCP Is Equivalent to Single Balloon Assisted ERCP in Patients with Roux-en-Y Anatomy

Increased Expression of VEGF, COX-2, and Ki-67 in Barrett’s Esophagus: Does the Length Matter?

Mast Cells and Intestinal Motility Disorders (Mastocytic Enteritis/Colitis)

Transient PPI Responsive Esophageal Eosinophilia May Be a Clinical Sub-phenotype of Pediatric Eosinophilic Esophagitis

A Prospective Randomized Controlled Trial of Preoperative Whole-Liver Chemolipiodolization for Hepatocellular Carcinoma

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials